ALLE vs EBS · P/E 21, rev $3.77B vs rev $1.04B
Allegion PLC (ALLE) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Allegion PLC (ALLE) is a security & protection services company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ALLE revenue for 2024-12-31 was $3.77B. Net income was $597.5M. Revenue was up 3.3% from 2023-12-31 to 2024-12-31. ALLE currently screens at market cap $12.71B and trailing P/E 20.7.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
ALLE currently screens at market cap $12.71B and trailing P/E 20.7. EBS currently screens at market cap $416.4M.
Not investment advice. Open the ALLE and EBS stock pages for the full models.
Not investment advice.